R&D Projects

ADELIS

Pharmacogenomic evaluation for the treatment of breast cancer with aromatase inhibitors

The project aims to develop a pharmacogenomic evaluation system for the treatment of breast cancer with aromatase inhibitors, using a new application designed by ROVI Laboratorios.

Its ultimate goal is the optimisation of drug delivery and release processes.

9

institutions and companies collaborating in the project

detailGrey

Adealis promotes the treatment of breast cancer with aromatase inhibitors

In order to successfully achieve the project’s objectives, Atrys Health collaborates with Laboratorios Rovi, Biomedadl, Vaxdyn, Hospital Vírgen del Rocío, the University of Granada, the University of Seville, the University of Cádiz, and Genyo.

 

To achieve the objectives

2013-2014

The project is funded by the FEDER-INNTERCONECTA Programme for Andalusia.

Financial backers

Related projects

DAPLIA

DAPLIA

Application of artificial intelligence for the diagnosis of lumbar pathologies

Read more
eDCardio

eDCardio

Telemedicine for the detection and prevention of cardiovascular diseases

Read more
eDSalud

eDSalud

Multispecialty telemedicine platform

Read more